`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`SAMSUNG BIOEPIS CO., LTD., CELLTRION INC,
`and BIOCON BIOLOGICS INC.
`Petitioners,
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Patent No. 11,253,572
`
`_______________
`
`Inter Partes Review No. IPR2023-008841
`
`____________________________________________________________
`
`DECLARATION OF MATTHEW M. WILK IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`1 IPR2024-00260 and IPR2024-00298 are joined with IPR2023-00884.
`
`Samsung et al. v. Regeneron IPR2023-00884
`Regeneron Pharmaceuticals, Inc. Exhibit 2241 Page 1
`
`
`
`IPR2023-00884
`
`I, Matthew M. Wilk, do hereby declare as follows:
`
`1.
`
`I am a member in good standing of the New York State Bar, to which I
`
`was admitted on December 10, 2018, and the Massachusetts State Bar, to which I
`
`was admitted on June 24, 2019.
`
`2.
`
`I am a senior associate at the law firm of Arnold & Porter Kaye Scholer
`
`LLP (“Arnold & Porter”). I began working at Arnold & Porter in February 2020. I
`
`have pharmaceutical patent litigation experience, including in United States District
`
`Courts and before the Patent Trial & Appeal Board. My patent litigation experience
`
`includes cases related to biologics and medical devices.
`
`3.
`
`I have never been suspended or disbarred from practice before any court
`
`or administrative body.
`
`4.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`5.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`6.
`
`I have read and will comply with the Office Patent Trial Practice Guide
`
`and the Board’s Rules of Practice for Trials set forth in 37 C.F.R. § 42.
`
`2
`
`Samsung et al. v. Regeneron IPR2023-00884
`Regeneron Pharmaceuticals, Inc. Exhibit 2241 Page 2
`
`
`
`IPR2023-00884
`
`7.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`8.
`
`I have applied to appear pro hac vice in the following proceedings
`
`before the USPTO: IPR2021-00880, IPR2021-00881, IPR2022-01225, IPR2022-
`
`01226, and IPR2023-00442. The USPTO granted my pro hac vice application in
`
`IPR2021-00880, IPR2021-00881, IPR2022-01225, IPR2022-01226, and IPR2023-
`
`00442.
`
`9.
`
`Adam R. Brausa (Reg. 60,287) is an experience registered patent
`
`attorney with whom I have worked in this proceeding and will continue to do so.
`
`10.
`
`I have significant familiarity with the subject matter at issue in this
`
`proceeding and have substantive knowledge of the patent at issue (U.S. Patent No.
`
`11,253,572 (the “’572 Patent”)) by virtue of my preparation for this proceeding. A
`
`significant amount of my time since March 2020 has been spent working on issues
`
`related to the ’572 Patent, related patents, and Patent Owner’s commercial product,
`
`Eylea. Therefore, I have a substantial familiarity with the subject matter of this
`
`proceeding.
`
`11.
`
`I hereby declare under penalty of perjury under the laws of the United
`
`States of America that the foregoing is true and correct, and that all statements made
`
`of my own knowledge are true and that all statements made on information and belief
`
`
`
`3
`
`Samsung et al. v. Regeneron IPR2023-00884
`Regeneron Pharmaceuticals, Inc. Exhibit 2241 Page 3
`
`
`
`IPR2023-00884
`
`are believed to be true. I understand that willful false statements are punishable by
`
`fine or imprisonment or both. See 18 U.S.C. § 1001.
`
`
`
`Dated: March 13, 2024
`
`
`
`
`
`
`
`
`
`
`
`/Matthew M. Wilk/
`Mathew M. Wilk
`
`4
`
`Samsung et al. v. Regeneron IPR2023-00884
`Regeneron Pharmaceuticals, Inc. Exhibit 2241 Page 4
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
